Representative genes involved in these pathways include GNB1, JAK1, RPS3, MAPK3, and IL6, suggesting that transcriptional responses in T2DM converge on inflammatory, oncogenic, and neurodegenerative signaling axes. This evidence concerns the gene RPS3 and type 2 diabetes mellitus.